← Leaderboards
Robert J Kaner
Weill Medical College Of Cornell Univ
$13,023,117
Attributed
$19,416,092
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,416,092 · 10
By mechanism
R01$5,651,610 · 3
UH3$5,484,720 · 1
P50$3,096,215 · 2
T32$1,586,104 · 1
UG3$1,432,888 · 1
R34$1,094,758 · 1
Top collaborators
- Marshall J Glesby6 shared
- Ronald G Crystal3 shared
- Jason G Mezey3 shared
- Heather Winona Stout Delgado2 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Ronald G Crystal$80,684,359
- Francis Barany$10,854,311
- Marshall J Glesby$7,651,029
- Steven S Gross$23,127,784
- Carl F Nathan$43,444,016
Others in their field
Top investigators on “Alveolar Macrophages”
- Bruce C Trapnell · Children'S Hospital Med Ctr (Cincinnati)$17,777,346
- David G Russell · Texas A&M University System$17,271,362
- Joseph P Mizgerd · Boston University Medical Campus$15,740,803
- Gr Scott Budinger · Northwestern University$15,091,729
- Paul Wesley Noble · Yale University$14,345,275
- Larry S. Schlesinger · Texas Biomedical Research Institute$13,968,349
Research focus
Alveolar MacrophagesGene ExpressionProteinsLungClinical ResearchBronchoscopyPhenotypeHiv InfectionsBaseSamplingEnrollmentBiologicalPreventPathogenesisHuman SubjectPulmonary EmphysemaRecruitment ActivityMatrix MetalloproteinasesClinical PhenotypeFundingChronic Obstructive Airway DiseaseBloodRandomizedDesign
Grant awards (36)
Multidisciplinary Approach Training in Respiratory Research$901,236
T32 · FY2025 · HL
Ancillary SOURCE Study: Characterization of Small Airway Basal Cell Biology in Early COPD$803,355
R01 · FY2025 · HL
1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial$1,259,310
UH3 · FY2024 · HL · contact PI
Ancillary SOURCE Study: Characterization of Small Airway Basal Cell Biology in Early COPD$787,290
R01 · FY2024 · HL
Multidisciplinary Approach Training in Respiratory Research$684,868
T32 · FY2024 · HL
1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial$2,092,028
UH3 · FY2023 · HL · contact PI
Ancillary SOURCE Study: Characterization of Small Airway Basal Cell Biology in Early COPD$799,965
R01 · FY2023 · HL
1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial$2,133,382
UH3 · FY2022 · HL · contact PI
1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial$1,432,888
UG3 · FY2021 · HL · contact PI
Doxycycline for COPD in HIV-Infected Patients$520,748
R34 · FY2013 · HL · contact PI
Doxycycline for COPD in HIV-Infected Patients$574,010
R34 · FY2012 · HL · contact PI
CORE--Clinical$322,951
P50 · FY2011 · HL · contact PI
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive$296,292
P50 · FY2011 · HL · contact PI
CORE--Clinical$322,951
P50 · FY2010 · HL · contact PI
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive$296,292
P50 · FY2010 · HL · contact PI
CORE--Clinical$322,951
P50 · FY2009 · HL · contact PI
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive$296,292
P50 · FY2009 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$224,109
U10 · FY2009 · HL · contact PI
CORE--Clinical$322,951
P50 · FY2008 · HL · contact PI
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive$296,292
P50 · FY2008 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$213,229
U10 · FY2008 · HL · contact PI
CORE--Clinical$322,951
P50 · FY2007 · HL · contact PI
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive$296,292
P50 · FY2007 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$211,244
U10 · FY2007 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$211,215
U10 · FY2006 · HL · contact PI
Alveolar Macrophage Host Defenses$339,000
R01 · FY2005 · HL
Idiopathic Pulmonary Fibrosis Clinical Research Network$210,000
U10 · FY2005 · HL
Vascular endothelial growth factor induced lung edema$339,000
R01 · FY2004 · HL
Alveolar Macrophage Host Defenses$339,000
R01 · FY2004 · HL
Vascular endothelial growth factor induced lung edema$339,000
R01 · FY2003 · HL
Alveolar Macrophage Host Defenses$339,000
R01 · FY2003 · HL
Alveolar Macrophage Host Defenses$339,000
R01 · FY2002 · HL
Vascular endothelial growth factor induced lung edema$339,000
R01 · FY2002 · HL
Vascular endothelial growth factor induced lung edema$339,000
R01 · FY2001 · HL
ALVEOLAR MACROPHAGE HOST DEFENSES$274,500
R01 · FY2001 · HL
ALVEOLAR MACROPHAGE HOST DEFENSES$274,500
R01 · FY2000 · HL